Introduction Acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019
(COVID-19) often leads to mortality. Outcomes of patients with COVID-19-related ARDS …

COVID-19 is characterized by two major clinical phases, the SARS-CoV-2 infection of target
cells and tissues, and a deep inflammatory state, known as “cytokine storm”, caused by …

Tocilizumab (TOC) is presumed to be an effective and safe treatment for severe COVID-19,
but its usefulness has not been yet investigated for different SARS-CoV-2 variants. This …

Objectives: Oxidative stress is implicated in several metabolic cascades involved in glucose
control. Hence, investigating antioxidant and antidiabetic activities is crucial for discovering …

Interactions between anti-hypertensive agents (ACEI), comorbidities, inflammation, and
stress status may impact hospital stay duration in COVID-19 patients. This retrospective …

Inflammatory aberrations constitute the major pathophysiological basis for most chronic
diseases. This study investigated the phytochemicals, safety profile, and anti-inflammatory …

The re-emergence of severe acute respiratory syndrome coronavirus 2 A (SARS-CoV-2) in
Wuhan, China, has placed an unprecedented economic and health burden globally. The …

Currently, the world is facing an unprecedented emergency pandemic caused by a novel
coronavirus, which is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes
coronavirus disease 2019 (COVID-19) is now the leading cause of death globally. This …

Пандемія COVID-19 і сьогодні залишається у центрі уваги світової науки, оскільки
безпрецедентно вплинула на світ своїми негативними наслідками. Потенційні шляхи …